Abstract
The aim of the study was to explore the extent of thrombocytopenia (TCP), anaemia and leucopenia in patients with hepatitis C and evaluate how they impact the management of antiviral therapy, the attainment of sustained virological response (SVR), and some therapy-related adverse events. The Scottish Hepatitis C Clinical Database was used in this retrospective study. The prevalence of TCP, anaemia and leucopenia was evaluated. The impact of the three deficiencies on antiviral therapy management, serious adverse events and SVR attainment was assessed in patients who received therapy.
Original language | English |
---|---|
Pages (from-to) | 398-404 |
Number of pages | 7 |
Journal | European Journal of Gastroenterology and Hepatology |
Volume | 28 |
Issue number | 4 |
Early online date | 21 Dec 2015 |
DOIs | |
Publication status | Published - Apr 2016 |
Keywords
- thrombocytopenia
- Hepatitis C
- antiviral therapy